首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >Synthesis of taurine–fluorescein conjugate and evaluation of its retina-targeted efficiency in vitro
【2h】

Synthesis of taurine–fluorescein conjugate and evaluation of its retina-targeted efficiency in vitro

机译:牛磺酸-荧光素偶联物的合成及其体外视网膜靶向作用的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this work, retinal penetration of fluorescein was achieved in vitro by covalent attachment of taurine to fluorescein, yielding the F–Tau conjugate. Nuclear magnetic resonance (NMR) and high resolution mass spectrometry (HRMS) were used to confirm the successful synthesis of F–Tau. The cellular uptake of F–Tau in adult retinal pigment epithelial cells (ARPE-19) and human retinal microvascular endothelial cells (hRMECs) was visualized via confocal scanning microscopy. The results indicated an improvement of solubility and a reduction of logP of F–Tau compared with fluorescein. As compared with fluorescein, F–Tau showed little toxicity, and was retained longer by cells in uptake experiments. F–Tau also displayed higher transepithelial permeabilities than fluorescein in ARPE-19 and hRMECs monolayer cells (P<0.05). These results showed that taurine may be a useful ligand for targeting small-molecule hydrophobic pharmaceuticals into the retina.
机译:在这项工作中,通过牛磺酸与荧光素的共价结合在体外实现了荧光素的视网膜渗透,产生了F–Tau偶联物。核磁共振(NMR)和高分辨率质谱(HRMS)用于确认F–Tau的成功合成。通过共聚焦扫描显微镜观察成年视网膜色素上皮细胞(ARPE-19)和人视网膜微血管内皮细胞(hRMEC)中F–Tau的细胞摄取。结果表明,与荧光素相比,F-Tau的溶解度有所提高,logP有所降低。与荧光素相比,F-Tau几乎没有毒性,在吸收实验中被细胞保留的时间更长。在ARPE-19和hRMECs单层细胞中,F-Tau的跨上皮通透性也比荧光素高(P <0.05)。这些结果表明,牛磺酸可能是将小分子疏水药物靶向视网膜的有用配体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号